Cooperative Agreement 2318892
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$1M
Federal Agency
National Science Foundation
Awardee
Athem LLC (F5X8LV38ETG7)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Research Triangle Park, Durham, NC, USA
Similar Awards
This $902,504 cooperative agreement from the National Science Foundation Division of Industrial Innovation under the Engineering program (CFDA 47.041) supports the development of a scalable downstream purification process for gene therapy vectors by Isolere Bio, Inc. of Durham, North Carolina. The non-chromatographic method seeks to address current inefficiencies that lead to single digit yields by utilizing a polypeptide-based reagent combining affinity capture with phase separation and...
This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $273,550 to Biocognon LLC for the development of a combinatorial platform to discover improved molecular recognition components for use in therapeutic and diagnostic antibodies. The project aims to utilize synthetic biology, next-generation DNA sequencing, and computational biology to efficiently generate and screen libraries of antibody...
This Project Grant award of $305,000.00 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program to Plexymer, Inc. in North Plainfield, NJ aims to develop an AI-driven platform to accelerate the bioformulation of antibody therapeutics. The project seeks to enable at-home self-administration of antibody medicines by pairing laboratory robotics with AI to rapidly identify stable, high-concentration formulations. This has the potential to...
This $255,982 National Science Foundation project grant supports the development of sustainable, cost-effective viral clearance membranes by Filtravate, Inc. to enable efficient monoclonal antibody processing. The NSF Technology, Innovation, and Partnerships program seeks technologies leading to breakthrough solutions for national challenges. Specifically, Filtravate will develop a virus filtration membrane using a synthesis process that is more sustainable and affordable than conventional...
This $2 million cooperative agreement from the National Science Foundation will support Protabit LLC in developing artificial intelligence-enabled antibody engineering approaches to generate neutralizing antibodies against SARS-CoV-2. Funded through Jul 2022 to Jun 2024 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the project aims to discover a large array of high-affinity neutralizing antibodies targeting multiple regions of the SARS-CoV-2 spike protein. This...
The National Science Foundation awarded Sarkar-Klein-Labs, LLC a $225,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support the STTR PHASE I: PROTEASE-BASED PURIFICATION OF RECOMBINANT HUMAN MATRIX METALLOPROTEASES project. This two-year project beginning February 1, 2021 aims to develop protease-based purification methods for recombinant human matrix metalloproteases, which are enzymes involved in tissue remodeling and disease processes. The...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...
This Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,250,000 in funding to Zaiput Flow Technologies LLC, a small business manufacturer based in Waltham, Massachusetts. The award supports the further development and scaling of Zaiput's innovative continuous crystallization device technology for pharmaceutical manufacturing. The project aims to address key challenges in the $500-billion...
The National Science Foundation (NSF) awarded a $1,250,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Micropure Genomics Inc., a minority-owned small business located in Middletown, DE. The funding supports the development of an innovative platform for preparing high-quality DNA samples to enable broader adoption of long-read sequencing technologies. Key objectives include fabricating user-friendly cartridges and instruments,...